A significant proportion of hospitalized patients with atrial fibrillation and no contraindications are discharged without appropriate antithrombotic therapy for stroke prevention.
Anticoagulation underuse persists in real-world AF; leaves open targeted strategies to address barriers.
Five randomised controlled trials show that warfarin reduces the risk of ischaemic strokes and death in patients with atrial fibrillation.' We suspected that many such patients were not receiving warfarin and therefore reviewed the records of previous inpatients with atrial fibrillation to see how many were receiving warfarin or aspirin and whether those who were not had a specific contraindication.
No takes yet. Share an insight, caveat, or question.
Bath et al. (1993) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: